Sinopep-Allsino Bio Pharmaceutical Co., Ltd. (688076.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 28.70

From 52W high−10.16%

Volume1.99M

Market capCNY 8.60B

P/E (TTM)25.9x

P/S (TTM)4.7x

Div yield1.21%

Key dataSep 18, 2026

Open

CNY 28.70

From 52W high

−10.16%

Volume

1.99M

Market cap

CNY 8.60B

ValuationView details →

P/E (Fwd)

40.3x

EV/EBITDA

14.9x

P/E (TTM)

25.9x

RSI (14)

56.4

MomentumView details →

1D Return

−0.70%

YTD Return

—

ValuationView details →

P/E (Fwd)

40.3x

P/E (TTM)

25.9x

EV/EBITDA

14.9x

EV/Sales

5.6x

P/S (TTM)

4.7x

P/B (TTM)

2.9x

ProfitabilityView details →

Gross Margin

60.23%

Net Margin

16.02%

EBITDA Margin

37.43%

ROE (TTM)

9.93%

ROA (TTM)

4.54%

Asset Turnover

0.28x

GrowthView details →

Revenue YoY

+5.21%

EPS YoY

−39.40%

FCF YoY

+38.52%

Revenue CAGR 3Y

+43.95%

EPS CAGR 3Y

+20.89%

EBITDA YoY

—

MomentumView details →

1D Return

−0.70%

YTD Return

—

1Y Return

—

RSI (14)

56.4

vs 50D SMA

+3.43%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.76x

Current Ratio

1.17x

Quick Ratio

0.75x

Div Yield

1.21%

Div Rate

CNY 0.35

Div Growth 1Y

+60.00%

EarningsView details →

EPS (Actual)

CNY 0.27

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

−12.96%

Financials snapshotView financials →

Revenue (TTM)

1.93B

Net Income (TTM)

309.27M

Op. CF (TTM)

683.73M

Next earningsOct 22, 2026 →

Latest newsMore news →

No recent news for 688076.SH.

Similar companies

Vaxcyte, Inc.PCVX TG Therapeutics, Inc.TGTX Ascletis Pharma Inc.01672.HK Caris Life Sciences, Inc.CAI Praxis Precision Medicines, Inc.PRAX ImmunityBio, Inc.IBRX Find similar companies →

Latest newsMore news →

No recent news for 688076.SH.